Evidence map›Paper›PMID 41053235›Full record

ArticleAAPS PharmSciTech2025

Dissolution Amelioration by Small Amounts of HPMC in the Difficult-to-solve Drug Combination Baicalein-imperatorin Co-Amorphous System: Dispersion and Crystallization Inhibition.

Tong Su, Xinli Liang, Qieying Jiang, Yu Tong, Mubarak G Bello, Gonglong Li, Zhenggen Liao

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tong SuKey Laboratory of Modern Chinese Medicine Preparations, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.ORCID http://orcid.org/0009-0003-7008-4350
Xinli LiangKey Laboratory of Modern Chinese Medicine Preparations, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.ORCID http://orcid.org/0000-0001-8644-2886
Qieying JiangJiangxi University of Traditional Chinese Medicine Laboratory Animal Science and Technology Center, Nanchang, 330004, China.ORCID http://orcid.org/0009-0004-3131-9636
Yu TongKey Laboratory of Modern Chinese Medicine Preparations, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.ORCID http://orcid.org/0009-0001-5432-2123
Mubarak G BelloKey Laboratory of Modern Chinese Medicine Preparations, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.ORCID http://orcid.org/0000-0002-6518-0749
Gonglong LiKey Laboratory of Modern Chinese Medicine Preparations, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China.ORCID http://orcid.org/0009-0004-3629-0668
Zhenggen LiaoKey Laboratory of Modern Chinese Medicine Preparations, Ministry of Education, Jiangxi University of Traditional Chinese Medicine, Nanchang, 330004, China. lyzlyg@163.com.ORCID http://orcid.org/0000-0003-3256-7549

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-drug co-amorphous systems (CAS) represent an emerging co-delivery strategy for combination therapy. Current research primarily explores combinations of poorly water-soluble drugs with water-soluble counterparts, while CAS comprising exclusively poorly water-soluble drugs remains underexplored. Such systems may exhibit unique dissolution behaviors due to the absence of hydrophilic components. In prior work, we developed a co-amorphous system of two poorly water-soluble drugs, baicalin (Bai) and imperatorin (Imp). However, this system demonstrated significant agglomeration during dissolution and limited dissolution enhancement. To address this, we incorporated trace hydroxypropyl methylcellulose (HPMC) into the Bai-Imp-CAS via spray drying. This study investigates HPMC's impact on dissolution behavior and underlying mechanisms through comprehensive analyses of supersaturation dissolution, dispersion kinetics, agglomeration rate, contact angle, surface free energy, nucleation time, and crystal growth rate. Results indicate that trace HPMC significantly enhances dissolution performance by reducing contact angles and increasing surface free energy, thereby improving dispersibility and inhibiting recrystallization. Additionally, HPMC elevates the glass transition temperature (Tg), improving physical stability. These findings provide a novel theoretical framework for optimizing poorly soluble drug combinations and offer practical solutions for co-delivery system development.Finally, it is also important to note that the degree of improvement of HPMC on the dissolution of the two drugs in the difficult-to-dissolve drug combination is also related to the solubility of the drugs themselves, their crystallization properties and the ratio of the two drugs.

Indexed as

FlavanonesFlavonoidsHypromellose DerivativesChemistry, PharmaceuticalCrystallizationDrug CombinationsDrug LiberationKineticsSolubilityWaterbaicaleinbaicalinDrug CombinationsFlavanonesFlavonoidsHypromellose DerivativesWaterbaicalinco-amorphous systemdispersionimperatorinwettability

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.